OLMA - Olema Pharmaceuticals Inc
Olema Pharmaceuticals Inc Logo

OLMA - Olema Pharmaceuticals Inc

https://olema.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company is headquartered in San Francisco, California.

52W High
$13.93
52W Low
$2.86
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
1.94
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-3.33
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
1.65
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
3.31%
Institutions (25–75% balanced)
104.76%
Shares Outstanding
68,634,000
Float
39,645,200
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-1.97
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-0.50%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
0.8723
Previous
0.8663
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025